• Science & Technology
• Health & Medicine

Prising open the trap: Getting to grips with targeted cancer drug resistance

Cancer Research UK-funded scientists are using innovative techniques to understand how resistance to a targeted cancer drug is unfolding. Cancer Research UK-funded scientists are using innovative techniques to understand how resistance to a targeted cancer drug is unfolding.

10 January 2022

• For Researchers

It’s a fair COP: Why our chief clinician went to a climate change summit

Charlie Swanton, our chief clinician, headed to the world’s most important climate change conference to talk about the links between pollution and lung cancer in never smokers... Charlie Swanton, our chief clinician, headed to the world’s most important climate change conference to talk about the links between pollution and lung cancer in never smokers...

13 December 2021

• For Supporters
• Science & Technology

Touching a nerve: How neuroscience could advance our understanding of cancer

The role of the nervous system in cancer progression remains largely unexplored. Now, our researchers at the Francis Crick Institute and Cancer Research UK Edinburgh Centre are leaning into the unknown to find out how cancer uses nerve cells and networks to survive and grow. The role of the nervous system in cancer progression remains largely unexplored. Now, our researchers at the Francis Crick Institute and Cancer Research UK Edinburgh Centre are leaning into the unknown to find out how cancer uses nerve cells and networks to survive and grow.

1 December 2021

• For Researchers

The incredible value of going public

We speak with two science communication masters about the benefits, ethics and sheer fun of communicating your research to the public. We speak with two science communication masters about the benefits, ethics and sheer fun of communicating your research to the public.

22 November 2021

• For Researchers

Professor Eithne Costello: On the road to early detection

Professor Eithne Costello on the challenges of ambitious trials, the evolution of early detection as a field in its own right and why a guiding framework is all important. Professor Eithne Costello on the challenges of ambitious trials, the evolution of early detection as a field in its own right and why a guiding framework is all important.

12 November 2021

• For Researchers

Taking on DNA repair to tackle cancer

Pioneering therapeutics targeting the damage repair mechanism of DNA polymerase theta in a range of cancers have entered human trials - we tell the story from discovery to translation. Pioneering therapeutics targeting the damage repair mechanism of DNA polymerase theta in a range of cancers have entered human trials - we tell the story from discovery to translation.

5 November 2021

• Health & Medicine

“The power of science”: HPV vaccine proven to dramatically reduce cervical cancer

New results find that the HPV vaccine was shown to dramatically reduce cervical cancer rates by 90% in women in their 20s who were offered it at age 12 to 13. New results find that the HPV vaccine was shown to dramatically reduce cervical cancer rates by 90% in women in their 20s who were offered it at age 12 to 13.

3 November 2021

• For Researchers

The director’s cut: How Dr Catherine Elliott sees the future of cancer research

We caught up with Director of Research, Dr Catherine Elliott, to talk pandemic recovery, research careers and the role of curiosity in a goal driven scientific environment We caught up with Director of Research, Dr Catherine Elliott, to talk pandemic recovery, research careers and the role of curiosity in a goal driven scientific environment

2 November 2021

• For Researchers

What the Budget 2021 means for research

The Comprehensive Spending Review has set out the Government’s spending plans for the next three years - but what do these plans mean for our research community and its work? The Comprehensive Spending Review has set out the Government’s spending plans for the next three years - but what do these plans mean for our research community and its work?

29 October 2021

• Science & Technology

Unravelling the mystery of Barrett’s oesophagus

Barrett’s oesophagus affects around 1 in every 100 to 200 people in the UK, and, for a small number of people, can develop into oesophageal cancer. But the origins of the condition have remained a mystery for decades, until now. Barrett’s oesophagus affects around 1 in every 100 to 200 people in the UK, and, for a small number of people, can develop into oesophageal cancer. But the origins of the condition have remained a mystery for decades, until now.

25 October 2021